External Validation and Recalculation of the CODEX Index in COPD Patients. A 3CIAplus Cohort Study

References

• Charles Joseph Singer EAU. A short history of medicine. Second ed. Oxford University Press; 1962.
   Google Scholar
• Evans CMM. Prognostic uncertainty in terminal care: can the Karnofsky index help? Lancet. 1985;1:1204–6.
   PubMed Web of Science ®Google Scholar
• Charlson ME, Pompei P, Ales KL MC. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–83.
   PubMedGoogle Scholar
• Salpeter SR, Luo EJ, Malter DS, Stuart B. Systematic review of noncancer presentations with a median survival of 6 months or less. Am J Med. 2012;125:512.e1–16.
   Web of Science ®Google Scholar
• Schünemann HJ, Dorn J, Grant BJ, Winkelstein WTM Jr. Pulmonary function is a long-term predictor of mortality in the general population: 29-year follow-up of the Buffalo Health Study. Chest. 2000;118(3):656–64.
   PubMed Web of Science ®Google Scholar
• Vogelmeier CF, Criner GJ, Martinez FJ, Anzueto A, Barnes PJ, Bourbeau J, Celli BR, Chen R, Decramer M, Fabbri LM, et al. Global Strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 Report. GOLD Executive Summary. Am J Respir Crit Care Med. 2017;195 (5):557–82.
   PubMed Web of Science ®Google Scholar
• Soriano JB, Lamprecht B, Ramírez AS, Martinez-Camblor P, Kaiser B, Alfageme I, Almagro P, Casanova C, Esteban C, Soler-Cataluña JJ, et al. Mortality prediction in chronic obstructive pulmonary disease comparing the GOLD 2007 and 2011 staging systems: A pooled analysis of individual patient data. Lancet Respir Med. 2015;3(6):443–50.
   PubMed Web of Science ®Google Scholar
• Almagro P, Martinez-Camblor P, Soriano JB, Marin JM, Alfageme I, Casanova C, Esteban C, Soler-Cataluña JJ, de-Torres JP, Celli BR, et al. Finding the best thresholds of FEV1and dyspnea to predict 5-year survival in COPD patients: The COCOMICS study. PLoS One. 2014;9(2):1–7.
   Web of Science ®Google Scholar
• Atsou K, Chouaid C, Hejblum G. Variability of the chronic obstructive pulmonary disease key epidemiological data in Europe: systematic review. BMC Med. 2011;9:7.
   PubMed Web of Science ®Google Scholar
• Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, Wedzicha JA. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax. 1999;54(7):581–6.
   PubMed Web of Science ®Google Scholar
• Nishimura K, Izumi T, Tsukino M, Oga T. Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD. Chest. 2002;121(5):1434–40.
   PubMed Web of Science ®Google Scholar
• Jones NL, Burrows B, Fletcher CM. Serial studies of 100 patients with chronic airway obstruction in London and Chicago. Thorax. 1967; 22(4):327–35.
   PubMed Web of Science ®Google Scholar
• Renzetti AD Jr. Prognosis in chronic obstructive pulmonary disease. Med Clin North Am. 1967;51:363–71.
   PubMed Web of Science ®Google Scholar
• Celli BR, Cote CG, Marin JM, Montes de Oca M, Mendez RA, Pinto Plata V, Cabral HJ. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med. 2004;350(10):1005–12.
   PubMed Web of Science ®Google Scholar
• Soler-Cataluña JJ, Martínez-García MÁ, Sánchez LS, Tordera MP, Sánchez PR. Severe exacerbations and BODE index: Two independent risk factors for death in male COPD patients. Respir Med. 2009;103(5):692–9.
   PubMed Web of Science ®Google Scholar
• Puhan MA, Hansel NN, Sobradillo P, Enright P, Lange P, Hickson D, Menezes AM, Riet GT, Held U, Domingo-Salvany A, et al. Large-scale international validation of the ADO index in subjects with COPD: An individual subject data analysis of 10 cohorts. BMJ Open. 2012;2:2012–152.
   Web of Science ®Google Scholar
• Jones RC, Donaldson GC, Chavannes NH, Kida K, Dickson-Spillmann M, Harding S, Wedzicha JA, Price D, Hyland ME. Derivation and validation of a composite index of severity in chronic obstructive pulmonary disease: the DOSE index. Am J Respir Crit Care Med. 2009;180(12):1189–95.
   PubMed Web of Science ®Google Scholar
• Esteban C, Quintana JM, Moraza J, Aburto M, Aguirre U, Aguirregomoscorta JI, Aizpiri S, Basualdo LV, Capelastegui A. BODE-Index vs HADO-score in chronic obstructive pulmonary disease: which one to use in general practice? BMC Med. 2010;8:28.
   PubMed Web of Science ®Google Scholar
• Almagro P, Soriano JB, Cabrera FJ, Boixeda R, Alonso-Ortiz MB, Barreiro B, Diez-Manglano J, Murio C, Heredia JL; Working Group on COPD, SpanishSociety of Internal Medicine. Short- and medium-term prognosis in patients hospitalized for COPD exacerbation: the CODEX index. Chest. 2014;145(5):972–80.
   PubMed Web of Science ®Google Scholar
• Navarro A, Costa R, Rodriguez-Carballeira M, Yun S, Lapuente A, Barrera A, Acosta E, Viñas C, Heredia JL, Almagro P. Prognostic assessment of mortality and hospitalizations of outpatients with advanced chronic obstructive pulmonary disease. Usefulness of the CODEX index. Rev Clin Esp . 2015;215(8):431–8.
   PubMed Web of Science ®Google Scholar
• Golpe R, Suárez-Valor M, Veres-Racamonde A, Cano-Jiménez E, Martín-Robles I, Sanjuán-López P, Pérez-de-Llano L. Octogenarian patients with chronic obstructive pulmonary disease: Characteristics and usefulness of prognostic indexes. Med Clin (Barc). 2017. [Epub ahead of print]
   Web of Science ®Google Scholar
• Echevarria C, Steer J, Heslop-Marshall K, Stenton SC, Hickey PM, Hughes R, Wijesinghe M, Harrison RN, Steen N, Simpson AJ, et al. The PEARL score predicts 90-day readmission or death after hospitalisation for acute exacerbation of COPD. Thorax. 2017;72(8):686–93.
   PubMed Web of Science ®Google Scholar
• Almagro P, Cabrera FJ, Diez J, Boixeda R, Alonso Ortiz MB, Murio C, Soriano JB; Working Group on, COPD, Spanish Society of Internal Medicine. Comorbidities and short-term prognosis in patients hospitalized for acute exacerbation of COPD: the EPOC en Servicios de medicina interna (ESMI) study. Chest. 2012;142(5):1126–33.
   PubMed Web of Science ®Google Scholar
• von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP; STROBE Initiative. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: Guidelines for reporting observational studies. Lancet. 2007;370(9596):1453–7.
   PubMed Web of Science ®Google Scholar
• Heagerty PJ, Lumley T, Pepe MS. Time-dependent ROC curves for censored survival data and a diagnostic marker. Biometrics. 2000;56(2):337–44.
   PubMed Web of Science ®Google Scholar
• Martínez-Camblor P, Bayón GF, Pérez-Fernández S. Cumulative/dynamic ROC curve estimation. J Stat Comput Simulat. 2016;86: 3582–94.
   Web of Science ®Google Scholar
• O'Quigley J, Stare J. Proportional hazards models with frailties and random effects. Stat Med. 2002;21(21):3219–33.
   PubMed Web of Science ®Google Scholar
• Dijk WD, Bemt Lv, Haak-Rongen Sv, Bischoff E, Weel Cv, Veen JC, Schermer TR. Multidimensional prognostic indices for use in COPD patient care. A systematic review. Respir Res. 2011;12:151.
   PubMed Web of Science ®Google Scholar
• Connors AF Jr, Dawson NV, Thomas C, Harrell FE Jr, Desbiens N, Fulkerson WJ, Kussin P, Bellamy P, Goldman L, Knaus WA. Outcomes following acute exacerbation of severe chronic obstructive lung disease. The SUPPORT investigators (study to understand prognoses and preferences for outcomes and risks of treatments). Am J Respir Crit Care Med. 1996;154(4):959–67.
   PubMed Web of Science ®Google Scholar
• Mannino D, Sin DD. Development and validation of a prognostic index for health outcomes in chronic obstructive pulmonary disease. Arch Intern Med. 2008;168(1):71–9.
   PubMedGoogle Scholar
• Sanjaume M, Almagro P, Rodríguez-Carballeira M, Barreiro B, Heredia JL, Garau J. Post-hospital mortality in patients re-admitted due to COPD. Utility of BODE index. Rev Clin Esp. 2009;209(8):364–70.
   PubMed Web of Science ®Google Scholar
• Cote CG, Dordelly LJ, Celli BR. Impact of COPD exacerbations on patient-centered outcomes. Chest. 2007;131:696–704.
   PubMed Web of Science ®Google Scholar
• Güell MR, Cejudo P, Ortega F, Puy MC, Rodríguez-Trigo G, Pijoan JI, Martinez-Indart L, Gorostiza A, Bdeir K, Celli B, Galdiz JB. Benefits of long-term pulmonary rehabilitation maintenance program in severe COPD Patients: 3 year follow-up. Am J Respir Crit Care Med. 2017;195(5):622–29.
   PubMed Web of Science ®Google Scholar
• Imfeld S, Bloch KE, Weder W, Russi EW. The BODE index after lung volume reduction surgery correlates with survival. Chest. 2006;129(4):873–8.
   PubMed Web of Science ®Google Scholar
• Lahzami S, Bridevaux PO, Soccal PM, Wellinger J, Robert JH, Ris HB, Aubert JD. Survival impact of lung transplantation for COPD. Eur Respir J. 2010; 36(1):74–80.
   PubMed Web of Science ®Google Scholar
• Steer J, Gibson J, Bourke SC. The DECAF Score: predicting hospital mortality in exacerbations of chronic obstructive pulmonary disease. Thorax. 2012;67(11):970–6.
   PubMed Web of Science ®Google Scholar
• Echevarria C, Steer J, Heslop-Marshall K, Stenton SC, Hickey PM, Hughes R, Wijesinghe M, Harrison RN, Steen N, Simpson AJ, et al. Validation of the DECAF score to predict hospital mortality in acute exacerbations of COPD. Thorax. 2016;71(2):133–40.
   PubMed Web of Science ®Google Scholar
• Jones RC, Price D, Chavannes NH, Lee AJ, Hyland ME, Ställberg B, Lisspers K, Sundh J, van der Molen T, Tsiligianni I, et al. Multi-component assessment of chronic obstructive pulmonary disease: an evaluation of the ADO and DOSE indices and the global obstructive lung disease categories in international primary care data sets. NPJ Prim Care Respir Med. 2016;26:16010.
   PubMed Web of Science ®Google Scholar
• Sundh J, Janson C, Lisspers K, Ställberg B, Montgomery S. The Dyspnea, Obstruction, Smoking, Exacerbation (DOSE) index is predictive of mortality in COPD. Prim Care Respir J. 2012;21(3):295–301.
   PubMedGoogle Scholar
• Celli BR, Marin JM, Cote CG, Aguirre A, Macario CC. Prognostic assessment of patients with COPD. Lancet. 2009;374(9705):1885.
   PubMedGoogle Scholar
• Marin JM, Alfageme I, Almagro P, Casanova C, Esteban C, Soler-Cataluña JJ, de Torres JP, Martínez-Camblor P, Miravitlles M, Celli BR, Soriano JB. Multicomponent indices to predict survival in COPD: the COCOMICS study. Eur Respir J. 2013;42(2):323–32.
   PubMed Web of Science ®Google Scholar
• Ou CY, Chen CZ, Yu CH, Shiu CH, Hsiue TR. Discriminative and predictive properties of multidimensional prognostic indices of chronic obstructive pulmonary disease: a validation study in Taiwanese patients. Respirology. 2014; 19(5):581–9.
   Web of Science ®Google Scholar
• Collins GS, de Groot JA, Dutton S, Omar O, Shanyinde M, Tajar A, Voysey M, Wharton R, Yu LM, Moons KG, Altman DG. External validation of multivariable prediction models: a systematic review of methodological conduct and reporting. BMC Med Res Methodol. 2014;14:40.
   PubMed Web of Science ®Google Scholar
• Nieboer D, van der Ploeg T, Steyerberg EW. Assessing discriminative performance at external validation of clinical prediction models. PLoS One. 2016;11(2):e0148820.
   PubMed Web of Science ®Google Scholar
• Donaldson GC, Wedzicha JA. The CODEX index: a collection or digest of laws: a code. Chest. 2014;145 (5):934–5.
   PubMed Web of Science ®Google Scholar
• Almagro P, Yun S, Sangil A, Rodríguez-Carballeira M, Marine M, Landete P, Soler-Cataluña JJ, Soriano JB, Miravitlles M. Palliative care and prognosis in COPD: a systematic review with a validation cohort.Int J Chron Obstruct Pulmon Dis. 2017; 12:1005–729.
   Web of Science ®Google Scholar
• Steyerberg EW. Prognosis Research Strategy (PROGRESS) 3: prognostic model research. PLoS Med. 2013;10(2):e1001381.
   PubMed Web of Science ®Google Scholar